| 영문 | isoniazid(INH) | 한글 | 이소니아지트 |
|---|---|---|---|
| 설명 | 항결핵제. 결핵균의 세포벽 합성을 방해하는 작용을 한다. 다른 항결핵제와 함께 사용하며 일반적으로 12~24개월 정도 사용한다. 부작용으로는 발열, 발진, 간장애, 빈혈, 환각, 식욕부진, 복통이 있을 수 있다. |
||
| Tabs | tablets |
|---|---|
| INH | Isoniazid |
| INH | inhalation; isoniazid; isonicotinic acid hydrazide |
| INH | Isoniazid |
|---|---|
| isoniazid | Isonicotinic acid hydrazide |
| tablets | Solid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form. (12 Dec 1998) |
|---|---|
| tablets, enteric-coated | Tablets coated with material that delays release of the medication until after they leave the stomach. (12 Dec 1998) |
| isoniazid | <drug> An orally administered drug used to eliminate tuberculosis infection in people without active disease. INH is also administered in combination with other drugs to treat active tuberculosis. Side effects include liver impairment and peripheral neuropathy (see). (09 Oct 1997) |
| isoniazid acetyltransferase | <enzyme> Used to study acetylator phenotype for metabolism of hydrazines and arylamine carcinogen Registry number: EC 2.3.1.- Synonym: isoniazide n-acetyltransferase, hydrazine n-acetyltransferase (26 Jun 1999) |
| isoniazid neuropathy | An axonal form of neuropathy seen in some patients treated with isoniazid. (05 Mar 2000) |
| isoniazid polyneuropathy | An axonal loss polyneuropathy seen in some patients treated with isoniazid. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|